Munich, Germany, May 1st 2021:
Assessing preclinical cardiac contractility without animal use, but with human iPSC-derived cardiomyocytes is not only attractive for people in the cardiac community!
Parliamentary State Secretary Thomas Rachel (representing the Federal Ministry of Education & Research) stopped by InnoVitro headquarters in Juelich to award them with a 200k grant for the support of the new project SMOOTH: “Semi–synthetic Muscle Organoids based On Tissue Hybrids”
Munich, Germany, April 17th 2020: Nanion Technologies GmbH, a leading provider of automated patch clamp and cell monitoring systems, announces the partnership with NEXEL Co., Ltd., specialists in the manufacturing of hiPSC-derived cells. Under the partnership NEXEL will provide demonstration infrastructure in South Korea for Nanion´s CardioExcyte 96 and FLEXcyte 96 cell monitoring systems, while Nanion will provide scientific proficiency in experimental design and assay development.
Munich, Germany, November 7th 2019: Nanion Technologies, a leading provider of automated electrophysiology systems, today announced its partnership with Assay.Works, experts in assay development and High Throughput Screening (HTS), who will be providing SURFE²R 96SE assays “As-a-Service” for membrane transporter research.
Membrane transport proteins, enabling active and secondary active transport of ions and solutes across the membrane, are important drug targets but may also be involved in unwanted side effects of novel drug candidates. As response to the growing demand in assay options for membrane transporters and to afford researchers access to SSM-based electrophysiology, Nanion and Assay.Works have entered into a partnership.
MUNICH, GERMANY, October 31st 2019: Nanion is pleased to announce not one, but two winners of the SURFE²R N1 grant award. The two winners: Dr. Camilo Perez (The Center for Molecular Life Sciences, University of Basel, Switzerland) and Dr. Dimitrios Fotiadis (Institute for Biochemistry and Molecular Medicine, University of Bern, Switzerland) convinced the grant committee with their proposed research projects on nanobodies inhibiting membrane transporters and the deorphanization and investigation of a group of transporters involved in antibiotic transport, respectively.